Navigation Links
Is HRT the Culprit? Fall in Breast Cancer Cases After Women Cease HRT

There has been an evident reduction in the breast cancer cases in 2003.// Researchers have been mulling over the reasons for this, and one conceivable reason has particularly caught their attention. Nearly millions of women had abandoned hormone replacement therapy in 2002. Whether mere reduction in HRT has brought out such a huge difference, is being debated over.

There has been an almost 7 percent reduction in the number of breast cancer cases, estimated at 14,000 women in the United States, who were in the age group of 50 to 69 yrs.

Dr. Clifford Hudis, chief of the Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center in New York said, "It is biologically plausible, and there is no other glaring change in public health to explain the change. This is more evidence that HRT is risky in terms of breast cancer."

Few experts have suggested that the findings are incomplete, not having considered all the facts that could have led to the reduction. However it is an optimistic statistic, which has raised the curiosity of the researchers.

The fall in breast cancer cases may also be due to fewer women getting screened for the affliction, opines another school of thought. Michael Thun, vice president of epidemiology and surveillance research of the American Cancer Society, said, “ At this point, it's still an intriguing and promising observation, but very early. Creates the false impression that incidence rates are falling, whereas what is actually happening is that many early tumors are not being detected."

Nevertheless, the exact reason for the falling breast cancer rates needs to be probed further, to enable a clear picture.

'"/>




Page: 1

Related medicine news :

1. Consensus on "Combination Therapy" for Breast Cancer
2. Breast cancer treatment to be determined by gene test
3. Breast Feeding prevents obesity later on in life
4. Breast milk is essential
5. Breast Cancer Surgery Causes Psychological problems
6. Breast cancer evidence
7. Letrozole Beats Tamoxifen in Breast Cancer Therapy
8. Breast screening among diabetic women
9. Breast feeding can alter hormones
10. Diet, Sunlight connected to Breast Cancer Risk
11. Additional Radiotheraphy for Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/23/2017)... ... July 23, 2017 , ... A 20-year-long study by a ... by the Minneapolis Veterans Administration Health Care System overwhelmingly supports growing evidence that prostate ... few benefits. , In the cases involved with this study, surgery did not ...
(Date:7/23/2017)... LA (PRWEB) , ... July 23, 2017 , ... ... to interact, thus improving communication, safety and patient-provider relationships. New tools are helping ... to results of the 19th Annual Health Care’s Most Wired® survey, released today ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a leading medical ... No. 9,038,640 by the United States Patent and Trademark Office. The patent applies ... Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and safety of ...
(Date:7/21/2017)... ... ... "As a doctor of lung medicine managing chest diseases for more than two ... inventor from Center Valley, Pa. "My idea is to improve the device to a ... PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means of draining pleural fluid from ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to families and business owners in northern Florida, ... that promises to provide support to area adults with developmental challenges. , The ...
Breaking Medicine News(10 mins):
(Date:6/30/2017)... , June 30, 2017  AVACEN Medical (AVACEN) announced the publication ... research describes the use of its AVACEN Treatment Method ... from fibromyalgia. ... AVACEN Medical ... by chronic widespread pain. It affects approximately 200 to 400 million people ...
(Date:6/27/2017)...  Therapix Biosciences Ltd. (Nasdaq: TRPX ) ... development of cannabinoid-based drugs, today announced that the Company ... New York, NY on Wednesday, ... offering (IPO) of American Depository Shares (ADSs) listed on ... Dr. Elran Haber, Ph.D., Chief Executive Officer of Therapix, ...
(Date:6/20/2017)... and LAGUNA HILLS, Calif. , ... of new data that validate the use of MMprofiler ... patients with multiple myeloma (MM). In a poster presentation ... Hematology Association (EHA) in Madrid, Spain ... MMprofiler for identifying high-risk elderly patients. ...
Breaking Medicine Technology: